Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes
Antioxidants · 20.05.2023 · 12 (5) · 1132
DOI: 10.3390/antiox12051132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.05.2023. Verfasst von Lidia Sojo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III, Agrupació Ciències Mèdiques, Girona.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Here, we report on our study of plasma lipidomics profiles of patients with type 1 diabetes (T1DM) and explore potential associations. One hundred and seven patients with T1DM were consecutively recruited. Ultrasound imaging of peripheral arteries was performed using a high image resolution B-mode ultrasound system. Untargeted lipidomics analysis was performed using UHPLC coupled to qTOF/MS. The associations were evaluated using machine learning algorithms. SM(32:2) and ether lipid species (PC(O-30:1)/PC(P-30:0)) were significantly and positively associated with subclinical atherosclerosis (SA). This association was further confirmed in patients with overweight/obesity (specifically with SM(40:2)). A negative association between SA and lysophosphatidylcholine species was found among lean subjects. Phosphatidylcholines (PC(40:6) and PC(36:6)) and cholesterol esters (ChoE(20:5)) were associated positively with intima-media thickness both in subjects with and without overweight/obesity. In summary, the plasma antioxidant molecules SM and PC differed according to the presence of SA and/or overweight status in patients with T1DM. This is the first study showing the associations in T1DM, and the findings may be useful in the targeting of a personalized approach aimed at preventing cardiovascular disease in these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.
- Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain.
- Department of Medical Sciences, School of Medicine, 17003 Girona, Spain.
ORCID-Profile: Lidia Sojo, Elena Santos-González, Rebeca Barahona, Maria Buxó, Jordi Mayneris-Perxachs, Mercè Fernandez-Balsells, José-Manuel Fernández-Real
Förderung
- European Regional Development Fund
- Instituto de Salud Carlos III
- Agrupació Ciències Mèdiques, Girona
- European Union
Zitieren
APA
Sojo, L., Santos-González, E., Riera, L., Aguilera, A., Barahona, R., Pellicer, P., Buxó, M., Mayneris-Perxachs, J., Fernandez-Balsells, M., & Fernández-Real, J. M. (2023). Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes. Antioxidants, 12(5), 1132. https://doi.org/10.3390/antiox12051132
Vancouver
Sojo L, Santos-González E, Riera L, Aguilera A, Barahona R, Pellicer P, et al. Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes. Antioxidants. 2023;12(5):1132. doi:10.3390/antiox12051132
BibTeX
@article{Sojo2023,
author = {Sojo, Lidia and Santos-González, Elena and Riera, Lídia and Aguilera, Alex and Barahona, Rebeca and Pellicer, Paula and Buxó, Maria and Mayneris-Perxachs, Jordi and Fernandez-Balsells, Mercè and Fernández-Real, José-Manuel},
title = {Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {5},
pages = {1132},
doi = {10.3390/antiox12051132}
}
EUVIMED